| Literature DB >> 24734052 |
Ava Mansouri1, Alireza Ahmadvand2, Molouk Hadjibabaie3, Mohammadreza Javadi3, Seyed Hamid Khoee3, Farzaneh Dastan4, Kheirollah Gholami3.
Abstract
Medication error (ME) is the most common preventable cause of adverse drug events which negatively affects patient safety. Inadequate, low-quality studies plus wide estimation variations in ME from developing countries including Iran, decreases the reliability of ME evaluations. To clarify sources, underreporting reasons and preventive measures of MEs, we reviewed Iran current available literature. We searched Scopus, WOS, PubMed, CINAHL, EBSCOHOST and Persian databases (IranMedex, and SID) up to October 2012. Two authors independently selected and one reviewed and extracted data. Results reported by more than 30% of studies considered as the most important topics. Finally 25 articles were included. All study designs were cross-sectional (except for two interventional studies) and in hospital settings. Nursing staff and students were the most observed populations. Individual factor, with "inadequate knowledge of medication" as its most frequent reason, were the mostly reported source of MEs. Fear and reporting process were two most important reporting barriers. The sense of being reprimanded and ignoring to report respectively were their most frequent factors. Anti-infectives were the most frequent drugs involved in MEs. Preventive measures were varied and reporting of their effectiveness was inconsistent. There are still many research gaps which need to be explored by further studies. Based on our findings, further researches may be focused on design, implementation, and evaluation of a ME reporting system as groundwork, assessing systems-related factors to ME alongside individual factors and evaluating the effectiveness of preventive measures for MEs in trials.Entities:
Keywords: Literature review; Medication errors; Preventive measures of medication errors; Reporting of medication errors; Source of medication errors
Year: 2014 PMID: 24734052 PMCID: PMC3985240
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Figure 1Search process and number of eligible studies
Characteristics of studies on ME included in our final review with their most frequent topics covered
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Sources of MEs | 12 | 2007-2012 |
Nursing staff ( Nursing students ( Nurse instructors ( Hospital officials ( | Cross-sectional |
|
| Under-reporting of MEs | 5 | 2008-2012 | Nursing staff ( | Cross-sectional |
|
| Preventing measures of MEs | 5 | 2008-2011 | Nurses ( | Cross-sectional; | **** |
| Drugs involved in MEs | 11 | 2007-2012 | Nurses ( | Cross-sectional; | Anti-infectives for systemic use ( |
* A few studies included more than one units of observation. So, the total units of observations may surpass the total number of studies.
** Topics which had been covered in over 30% of studies were mentioned as most frequent.
*** Based on Anatomical Therapeutic Chemical (ATC) Classification System.
**** Inconsistency of topics and the diversity of reporting limited us to provide 3 most frequent topics in this category.
MAEs: Medication Administration Errors, IV: Intravenous.
Detailed characteristics of studies on sources of ME with their most frequent findings
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| 12.76% |
| Cross-sectional; | 64 | Nurses |
(
[ | 1 |
| Mean score SD |
| Cross-sectional; | 200 | Nurses |
(
[ | 2 |
| Mean score SD |
| Cross-sectional; | 22 | Nurse instructors |
(
[ | 3 |
| 29.72% |
| Cross-sectional; | 78 | Nursing students |
(
[ | 4 |
| 62% |
| Cross-sectional; | 100 | Nurses |
(
[ | 5 |
| 100% |
| Cross-sectional; | 86 | Nurses |
(
[ | 7 |
| 18.95% |
| Cross-sectional; | 52 | Nursing student |
(
[ | 6 |
| 15.25% |
| Cross-sectional; | 76 | Nursing student |
(
[ | 8 |
| 20.00% |
| Cross-sectional; | 60 | Nursing student |
(
[ | 9 |
| 66.7% |
| Cross-sectional; | 40 | Nurses |
(
[ | 10 |
| Studies which categorized sources of medication error un-comparable to classification by Vincent ( | ||||||
| Mean |
| Cross-sectional; | 286 | Nurses |
(
[ | 11 |
|
|
| Cross-sectional; | 396 | Hospital officials |
(
[ | 12 |
a Percentage of variance from factor analysis, b factor loadings
* Have been categorized as physical and mental health.
** Have been categorized as illegible orders or handwriting.
Detailed characteristics of studies on underreporting of ME with their most frequent findings.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| Mean score |
| Cross-sectional; | 200 | Nurses | Hosseinzadeh M, | 1 |
| Mean score |
| Cross-sectional; | 140 | Personnel | Tol A, | 2 |
| 23.3% |
| Cross-sectional; | 332 | Nurses; | Zahmatkeshan N, | 3 |
| Mean score** |
| Cross-sectional; | 240 | Nursing students |
4 Koohestani HR, | 4 |
| Mean score |
| Cross-sectional; | 76 | Nursing students | ( | 5 |
* All categorized as “being reprimanded”. ** The scoring scale used by Koohestani et al. ranged between 1 to 6 (25); we adjusted it to scales by other authors which ranged between 1 to 5.
Detailed characteristics of studies on preventing ME with their most frequent findings
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| 91.2% |
| Non randomized clinical trial | 603 | IV administration by nurses | Sharifi N, | 1 |
|
|
| Cross-sectional; | 396 | Hospital officials | Nasiripour AA, | 2 |
| 40% | Increasing duration of theoretical education for pharmacology course | Cross-sectional; | 22 | Nurse instructors | Baghcheghi N, | 3 |
| 52% |
| Before-after interventional study | 248 | Patients | Kazemi A, | 4 |
| 98.8% | Increasing number of staff proportional to patient load | Cross-sectional; | 86 | Nurses | Ghasemi F, | 5 |
CPOE: Computerized Physician Orders Entry; CDSS: Clinical Decision Support System
a Percentage of variance in preventing nursing practice from factor analysis, b factor loadings
Detailed characteristics of studies on most frequent drugs with ME and their findings
|
|
|
|
|
| |
|---|---|---|---|---|---|
| NA | Ceftriaxone | Endocrinology & nephrology | Nursing students | Ebrahimi Rigi Tanha Z, | 1 |
| 23.5% | Antimicrobials | Intensive Care Units (ICU) | IV administration by nurses | Vazin A, | 2 |
| 62.0% | Albumin | Internal | IV administration by nurses | Sharifi N, | 3 |
| 38.4% | Immunosuppressive | Nephrology | Patients | Vessal G. | 4 |
| 76.2% | Intravenous fluids | Pediatric | Pediatrics’ medical charts | Mohsenzade A, | 5 |
| NA | Aspirin | Emergency | Nursing students | Mohammadnejad E, | 6 |
| 27% | Antibiotics | ICU | Nurses | Nikpeyma N, | 7 |
| 11.0% | Amikacin | ICU | IV administration by nurses | Fahimi F, | 8 |
| 6.5% | Heparin | Internal | Nursing student | Baghcheghi N, | 9 |
| NA | Heparin | CCU | Nursing student | Koohestani HR, | 10 |
| 30% | Three NitroGlycerin | ICU | Infusion pump doses | Fahimi F, | 11 |